254 related articles for article (PubMed ID: 37387351)
1. A comparison of the International Consensus and 5th WHO classifications of T-cell lymphomas and histiocytic/dendritic cell tumours.
Falini B; Lazzi S; Pileri S
Br J Haematol; 2023 Nov; 203(3):369-383. PubMed ID: 37387351
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas.
Falini B; Martino G; Lazzi S
Leukemia; 2023 Jan; 37(1):18-34. PubMed ID: 36460764
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia.
Falini B; Martelli MP
Am J Hematol; 2023 Mar; 98(3):481-492. PubMed ID: 36606297
[TBL] [Abstract][Full Text] [Related]
4. A Comparison of the Fifth World Health Organization and the International Consensus Classifications of Mature T-Cell Lymphomas.
Piccaluga PP; Khattab SS
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762472
[TBL] [Abstract][Full Text] [Related]
5. [The 5th edition of the WHO classification of lymphoid neoplasms-an overview].
Kurz KS; Ott G
Pathologie (Heidelb); 2022 Aug; 43(Suppl 1):64-70. PubMed ID: 36239779
[TBL] [Abstract][Full Text] [Related]
6. Classifications of cutaneous lymphomas and lymphoproliferative disorders: An update from the EORTC cutaneous lymphoma histopathology group.
Kempf W; Mitteldorf C; Cerroni L; Willemze R; Berti E; Guenova E; Scarisbrick JJ; Battistella M
J Eur Acad Dermatol Venereol; 2024 Apr; ():. PubMed ID: 38581201
[TBL] [Abstract][Full Text] [Related]
7. The 5th edition of the World Health Organization Classification of mature lymphoid and stromal tumors - an overview and update.
Attygalle AD; Chan JKC; Coupland SE; Du MQ; Ferry JA; Jong D; Gratzinger D; Lim MS; Naresh KN; Nicolae A; Ott G; Rosenwald A; Schuh A; Siebert R
Leuk Lymphoma; 2024 Apr; 65(4):413-429. PubMed ID: 38189838
[TBL] [Abstract][Full Text] [Related]
8. Haematolymphoid malignancies: It is not important WHO we are but WHERE we go from here.
Lim MS
Br J Haematol; 2023 Nov; 203(3):349-350. PubMed ID: 37605456
[TBL] [Abstract][Full Text] [Related]
9. Artificial intelligence and classification of mature lymphoid neoplasms.
Carreras J; Hamoudi R; Nakamura N
Explor Target Antitumor Ther; 2024; 5(2):332-348. PubMed ID: 38745770
[TBL] [Abstract][Full Text] [Related]
10. [Primary Central Nervous System Lymphoma].
Sasaki N
No Shinkei Geka; 2023 Sep; 51(5):901-909. PubMed ID: 37743342
[TBL] [Abstract][Full Text] [Related]
11. [Classification of indolent B-cell lymphomas : Novelties and open questions].
Anagnostopoulos I; Zamò A
Pathologie (Heidelb); 2023 May; 44(3):154-165. PubMed ID: 37093245
[TBL] [Abstract][Full Text] [Related]
12. [Classification of aggressive B-cell lymphomas : News and open questions].
Rosenwald A; Menter T; Dirnhofer S
Pathologie (Heidelb); 2023 May; 44(3):166-172. PubMed ID: 36918411
[TBL] [Abstract][Full Text] [Related]
13. Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.
Satou A; Bennani NN; Feldman AL
Expert Rev Hematol; 2019 Oct; 12(10):833-843. PubMed ID: 31365276
[No Abstract] [Full Text] [Related]
14. Updates in the Classification of T-cell Lymphomas and Lymphoproliferative Disorders.
Oishi N; Ahmed R; Feldman AL
Curr Hematol Malig Rep; 2023 Dec; 18(6):252-263. PubMed ID: 37870698
[TBL] [Abstract][Full Text] [Related]
15. Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.
Jiang M; Bennani NN; Feldman AL
Expert Rev Hematol; 2017 Mar; 10(3):239-249. PubMed ID: 28133975
[TBL] [Abstract][Full Text] [Related]
16. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
Alaggio R; Amador C; Anagnostopoulos I; Attygalle AD; Araujo IBO; Berti E; Bhagat G; Borges AM; Boyer D; Calaminici M; Chadburn A; Chan JKC; Cheuk W; Chng WJ; Choi JK; Chuang SS; Coupland SE; Czader M; Dave SS; de Jong D; Du MQ; Elenitoba-Johnson KS; Ferry J; Geyer J; Gratzinger D; Guitart J; Gujral S; Harris M; Harrison CJ; Hartmann S; Hochhaus A; Jansen PM; Karube K; Kempf W; Khoury J; Kimura H; Klapper W; Kovach AE; Kumar S; Lazar AJ; Lazzi S; Leoncini L; Leung N; Leventaki V; Li XQ; Lim MS; Liu WP; Louissaint A; Marcogliese A; Medeiros LJ; Michal M; Miranda RN; Mitteldorf C; Montes-Moreno S; Morice W; Nardi V; Naresh KN; Natkunam Y; Ng SB; Oschlies I; Ott G; Parrens M; Pulitzer M; Rajkumar SV; Rawstron AC; Rech K; Rosenwald A; Said J; Sarkozy C; Sayed S; Saygin C; Schuh A; Sewell W; Siebert R; Sohani AR; Tooze R; Traverse-Glehen A; Vega F; Vergier B; Wechalekar AD; Wood B; Xerri L; Xiao W
Leukemia; 2022 Jul; 36(7):1720-1748. PubMed ID: 35732829
[TBL] [Abstract][Full Text] [Related]
17. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
Davis K; Sheikh T; Aggarwal N
Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
[TBL] [Abstract][Full Text] [Related]
18. New developments in non-Hodgkin lymphoid malignancies.
Ganapathi KA; Brown LE; Prakash S; Bhargava P
Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
[TBL] [Abstract][Full Text] [Related]
19. Who is WHO and what was REAL?
Cogliatti SB; Schmid U
Swiss Med Wkly; 2002 Dec; 132(43-44):607-17. PubMed ID: 12587044
[TBL] [Abstract][Full Text] [Related]
20. Large B-Cell Lymphomas in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms-Updated Classification and New Concepts.
Kurz KS; Ott M; Kalmbach S; Steinlein S; Kalla C; Horn H; Ott G; Staiger AM
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
